Biomarin Pharmaceutical (BMRN) Q3 2020 Earnings

4AugConfirmed
Q4 2019
Q1 2020
Q2 2020
Q3 2020
-0.08
0.09
0.27
0.44

Details

Expected EPS
-0.08
Actual EPS
-0.02
Surprise EPS
0.06
Surprise Percent
+75%

Description

Biomarin Pharmaceutical (BMRN) has reported earnings of -0.02 per share for Q3 2020.

0 Comments

Share your thoughts